Epidemiology, symptomatology and treatment of patients with myasthenia gravis in an Australian hospital

被引:3
作者
Li, Vivien [1 ]
Jasinarachchi, Mahi [1 ]
Butler, Ernest [1 ,2 ]
机构
[1] Frankston Hosp, Peninsula Hlth, Dept Neurol, Melbourne, Vic, Australia
[2] Natl Hosp Neurol & Neurosurg, Mailbox 71, London WC1N 3BG, England
关键词
myasthenia gravis; epidemiology; treatment; intravenous immunoglobulin; thymectomy; IMMUNOGLOBULIN;
D O I
10.1111/imj.14662
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Myasthenia gravis (MG) is a disorder affecting neuromuscular transmission with heterogeneous manifestations and treatments. This study describes clinical features and management of MG patients at a metropolitan hospital in Australia. Overall findings were consistent with previously published data. However, frequency of intravenous immuno-globulin use was higher, reasons for which are explored. Management is best conducted through specialist clinics with necessary expertise and standardised treatment protocols.
引用
收藏
页码:1537 / 1540
页数:5
相关论文
共 50 条
  • [21] Myasthenia gravis: Study of 153 patients
    Da Cunha, FMB
    ARQUIVOS DE NEURO-PSIQUIATRIA, 1998, 56 (3A) : 512 - 513
  • [22] Treatment for diplopia in patients with myasthenia gravis
    Park, Kyung-Ah
    Oh, Sei Yeul
    GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2013, 251 (03) : 895 - 901
  • [23] Treatment for diplopia in patients with myasthenia gravis
    Kyung-Ah Park
    Sei Yeul Oh
    Graefe's Archive for Clinical and Experimental Ophthalmology, 2013, 251 : 895 - 901
  • [24] Gender and quality of life in myasthenia gravis patients from the myasthenia gravis foundation of America registry
    Lee, Ikjae
    Kaminski, Henry J.
    Xin, Haichang
    Cutter, Gary
    MUSCLE & NERVE, 2018, 58 (01) : 90 - 98
  • [25] Treatment principles in the management of autoimmune myasthenia gravis
    Richman, DP
    Agius, MA
    MYASTHENIA GRAVIS AND RELATED DISORDERS: BIOCHEMICAL BASIS FOR DISEASE OF THE NEUROMUSCULAR JUNCTION, 2003, 998 : 457 - 472
  • [26] Treatment of Myasthenia Gravis Based on Its Immunopathogenesis
    Kim, Jee Young
    Park, Kee Duk
    Richman, David P.
    JOURNAL OF CLINICAL NEUROLOGY, 2011, 7 (04): : 173 - 183
  • [27] Italian recommendations for the diagnosis and treatment of myasthenia gravis
    Evoli, Amelia
    Antonini, Giovanni
    Antozzi, Carlo
    DiMuzio, Antonio
    Habetswallner, Francesco
    Iani, Cesare
    Inghilleri, Maurizio
    Liguori, Rocco
    Mantegazza, Renato
    Massa, Roberto
    Pegoraro, Elena
    Ricciardi, Roberta
    Rodolico, Carmelo
    NEUROLOGICAL SCIENCES, 2019, 40 (06) : 1111 - 1124
  • [28] Current and emerging therapies for the treatment of myasthenia gravis
    Mantegazza, Renato
    Bonanno, Silvia
    Camera, Giorgia
    Antozzi, Carlo
    NEUROPSYCHIATRIC DISEASE AND TREATMENT, 2011, 7 : 151 - 160
  • [29] Ravulizumab for the treatment of myasthenia gravis
    Vanoli, Fiammetta
    Mantegazza, Renato
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2023, 23 (03) : 235 - 241
  • [30] Current Treatment of Myasthenia Gravis
    Alhaidar, Mohammed K.
    Abumurad, Sumayyah
    Soliven, Betty
    Rezania, Kourosh
    JOURNAL OF CLINICAL MEDICINE, 2022, 11 (06)